Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Other Working Capital Changes (2021 - 2025)

Coeptis Therapeutics Holdings has reported Other Working Capital Changes over the past 5 years, most recently at $861993.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $861993.0 for Q4 2025, up 8815.8% from a year ago — trailing twelve months through Dec 2025 was $473497.0 (up 1344.51% YoY), and the annual figure for FY2025 was $473497.0, up 1344.51%.
  • Other Working Capital Changes for Q4 2025 was $861993.0 at Coeptis Therapeutics Holdings, up from -$547733.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for COEPW hit a ceiling of $861993.0 in Q4 2025 and a floor of -$547733.0 in Q3 2025.
  • Median Other Working Capital Changes over the past 5 years was $537.0 (2023), compared with a mean of $47078.8.
  • Biggest five-year swings in Other Working Capital Changes: plummeted 1941.71% in 2024 and later soared 8815.8% in 2025.
  • Coeptis Therapeutics Holdings' Other Working Capital Changes stood at $31828.0 in 2021, then soared by 1439.06% to $489853.0 in 2022, then plummeted by 99.89% to $537.0 in 2023, then plummeted by 1941.71% to -$9890.0 in 2024, then soared by 8815.8% to $861993.0 in 2025.
  • The last three reported values for Other Working Capital Changes were $861993.0 (Q4 2025), -$547733.0 (Q3 2025), and $222111.0 (Q2 2025) per Business Quant data.